[Elsevier] Mortality and adverse events of special interest with intravenous belimumab for adults with active, autoantibody-positive systemic lupus erythematosus (BASE): a multicentre, double-blind, randomised, placebo-controlled, phase 4 trial

tulho Post time 2022-9-28 01:36:40 | Show all posts |Read mode
Reward10points

DOI: 10.1016/S2665-9913(20)30355-6

Article link: https://www.thelancet.com/journals/lanrhe/article/PIIS2665-9913(20)30355-6/fulltext

Article author: Sheikh, Saira Z; et al.

Remark:

Best Answer

Please adopt

View Full Content

Reply

Use magic Donate Report

All Reply1 Show all posts
George Post time 2022-9-28 01:36:41 | Show all posts

This post has been completed

Completed attachments will be deleted within 24 hours.
Reply

Use magic Donate Report


Junior Member
  • post

  • reply

  • points

    60

Latest Reply



Return to the list